Skip to content

A Deep Dive into Deep Research Tools

Generative AI is transforming how knowledge work is done by introducing a new class of tools that go far beyond basic question-answering. Deep research tools are enabling professionals across industries to generate comprehensive, well-sourced reports, synthesize complex information, and surface critical insights in minutes.

By combining retrieval-augmented generation (RAG) with proprietary and public datasets, these tools deliver faster, smarter, and more tailored ways to research, analyze, and act on information.

In this report, discover:

  • How deep learning tools are redefining the research process by producing comprehensive, citation-rich outputs tailored to specific user needs
  • The key players shaping the deep research landscape
  • The critical trade-offs to consider: speed vs. depth, cost, data access, accuracy, formatting, and usability
  • What to expect as deep research tools continue to evolve

Explore more

APAC Macro Briefing 2026: Risk Meets Opportunity

In this report, we show how resources and workflows available in the AlphaSense platform can help contextualize the APAC macro environment, exploring the key implications for corporate leaders and investors across sectors.
Title slide for "APAC Macro Briefing 2026: Risk Meets Opportunity" with a map of the Asia-Pacific region.

Top AI Use Cases for Private Equity

In this report, discover how private equity teams are leveraging AI to accelerate conviction with speed. With purpose built, AI-driven solutions like AlphaSense, teams are gaining a competitive advantage with custom workflows and unmatched content sets for the most differentiated deal intelligence.
Top AI Use Cases For Private Equity by Barb Tague, Financial Research Leader. Illustration featuring isometric buildings and currency symbols.

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.